Clinical features and prognosis of adult-onset still's disease: 61 Cases from China

Journal of Rheumatology

Volumn 36, Issue 5, 2009, Pages 1026-1031

  Zeng, Ting ^a   Zou, Yu Qiong ^a   Wu, Mei Fang ^a   Yang, Cheng De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adult onset Still's disease; Prognosis; Refractory

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CHLOROQUINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FERRITIN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; PREDNISONE; RHEUMATOID FACTOR;

ADULT; ADULT ONSET STILL DISEASE; ARTHRITIS; ARTHROPATHY; ARTICLE; CHINA; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FOLLOW UP; HUMAN; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LEUKOCYTOSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; RASH; RELAPSE; RESPIRATORY FAILURE; RISK ASSESSMENT; ASIAN; CAUSE OF DEATH; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT FAILURE;

ADULT; ARTHRITIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD SEDIMENTATION; CAUSE OF DEATH; CHINA; EXANTHEMA; FEMALE; FEVER; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STILL'S DISEASE, ADULT-ONSET; SURVIVAL RATE; TREATMENT FAILURE; YOUNG ADULT;

EID: 67449086716     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080365     Document Type: Article

References (37)

1. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.
2. Kontzias A, Efthimiou P. Adult-onset Still's disease: Pathogenesis, clinical manifestations and therapeutic advances. Drugs 2008;3:319-37.
3. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
4. Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult onset Still's disease. Clinical course and outcome. Arthritis Rheum 1987;30:186-94.
5. Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194-200.
6. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: Manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-36.
7. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
8. Uppal SS, Pande IR, Kumar A, et al. Adult onset Still's disease in northern India: Comparison with juvenile onset Still's disease. Br J Rheumatol 1995;34:429-34.
9. Mok CC, Lau CS, Wong RW. Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese. J Rheumatol 1998;25:2345-51.
10. Garcia-Porrua C, Gonzalez-Gay MA, Crespo F, et al. Adult onset Still's disease in Catalonia, Spain. J Rheumatol 2000;27:280-1.
11. Louthrenoo W, Aramsareewong T, Sukitawut W. Adult onset Still's disease: Clinical features and outcome in 16 Thai patients. J Clin Rheumatol 2001;7:301-7.
12. Al-Arfaj AS, Al-Saleh S. Adult-onset Still's disease in Saudi Arabia. Clin Rheumatol 2001;20:197-200.
13. Mert A, Ozaras R, Tabak F, et al. Fever of unknown origin: A review of 20 patients with adult-onset Still's disease. Clin Rheumatol 2003;22:89-93.
14. Appenzeller S, Castro GR, Costallat LT, et al. Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005;11:76-80.
15. Evensen KJ, Nossent HC. Epidemiology and outcome of adult-onset Still's disease in Northern Norway. Scand J Rheumatol 2006;35:48-51.
16. Pay S, Türkçapar N, Kalyoncu M, et al. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006;25:639-44.
17. Riera Alonso E, Olive Marques A, Salles Lizarzaburu M, et al. Adult onset Still's disease: Review of 26 cases. Med Clin (Barc) 2007;129:258-61.
18. Uppal SS, Al-Mutairi M, Hayat S, et al. Ten years of clinical experience with adult onset Still's disease: Is the outcome improving? Clin Rheumatol 2007;26:1055-60.
19. Singh S, Samant R, Joshi VR. Adult onset Still's disease: A study of 14 cases. Clin Rheumatol 2008;27:35-9.
20. Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still's disease: A multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.
21. Pouchot J. How can we improve the management of adult-onset Still's disease? Joint Bone Spine 2007;74:117-9.
22. Kontzias A, Efthimiou P. Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 2008;68:319-37.
23. Reginato AJ, Schumacher HR Jr, Baker DG, et al. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 1987;17:39-57.
24. Taillan B, Fuzibet JG, Vinti H, et al. Non-infectious mitral endocarditis during Still's disease in adults. A case with histologic study of the endocardium. Ann Med Interne 1990;141:78-9.
25. Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis 1990;49:283-5.
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
27. Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 2006;36:144-52.
28. Akritidis N, Papadopoulos A, Pappas G. Long-term follow-up of patients with adult-onset Still's disease. Scand J Rheumatol 2006;35:395-7.
29. Sayarlioglu M, Ucmak H, Ozkaya M, et al. Leflunomide and methotrexate combination in refractory adult-onset Still's disease. Ann Pharmacother 2007;41:1319-20.
30. Cefle A. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother 2005;39:764-7.
31. Meaux-Ruault N, Magy N, Gil H, Dupond JL. Efficacy of thalidomide in refractory adult Still's disease: A new case report. Clin Exp Rheumatol 2003;21:272.
32. Iwamoto M, Nara H, Hirata D, et al. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum 2002;46:3388-9.
33. Kokkinos A, Iliopoulos A, Greka P, et al. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 2004;23:45-9.
34. Ahmadi-Simab K, Lamprecht P, Jankowiak C, et al. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006;65:1117-8.
35. Fitzgerald AA, Leclercq SA, Yan A, et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005;52:1794-803.
36. Kotter I, Wacker A, Koch S, et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: Four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 2007;37:189-97.
37. Yang DH, Chang DM, Lai JH. Etanercept as a rescue agent in patients with adult onset Still's disease complicated with congestive heart failure. Rheumatol Int 2008;29:95-8.